SKIP TO
CONTENT
Quince False Advertising Investigation
featured news
June 14, 2013
General
Court Rules Employee is Entitled to Dodd-Frank Whistleblower Protections
Setting an important precedent for all SEC whistleblowers, a district court recently issued a ruling concerning the anti-retaliation provisions of the Dodd-Frank Wall Street Reform & Consumer Protection Act. Last month, the court ruled that whistleblowers need not report incidents of fraud directly to the United States Securities and Exchange […]
June 13, 2013
General
SEC Whistleblower was Key to Enforcement Action Against Institutional Shareholder Services
Once again, the Securities and Exchange Commission (SEC) whistleblower program has proven to be a vital tool in the fight against securities fraud. After receiving a critical whistleblower tip concerning securities fraud within a Maryland-based proxy adviser firm, the SEC was able to quickly move forward with administrative proceedings. A […]
June 10, 2013
General
Understanding the Dodd-Frank Whistleblower Provisions
Both the government and whistleblowers alike have historically relied on the False Claims Act as a primary tool to end to fraud. It is important to understand, however, that the False Claims Act does have limitations. The largest one being that it only applies to instances in which the United […]
May 29, 2013
General
Jury Finds State Farm Guilty in False Claims Act Lawsuit
After a lengthy legal battle, a panel of 12 jury members in Mississippi federal court found State Farm Fire and Casualty Co. (State Farm) guilty of violating the False Claims Act. State Farm, the country’s largest insurer of homes, faced allegations that it defrauded the National Flood Insurance Program (NFIP) […]
May 27, 2013
General
U.S. Renal Care Settles False Claims Act Lawsuit for $7.3 Million
A Texas-based dialysis clinic recently agreed to a $7.3 million settlement with the United States government, resolving allegations of Medicare fraud contained in a False Claims Act lawsuit. U.S. Renal Care, who acquired Dialysis Corporation of America (DCA) in June 2010, is accused of knowingly overbilling Medicare for Epogen, a […]
Contact UsFree Case Evaluation
"*" indicates required fields
By clicking SUBMIT you agree to our Terms of Use and Privacy Policy and you are providing express consent to receive communications from Berger Montague via calls, emails, and/or text messages.
featured investigations
$2.4B+
in 2025 post-trial judgments
$50B+
in Settlements & Verdicts
55+
Years of Experience With High-Profile Cases
100+
Attorneys Protecting Your Rights
20+
Years Ranked as Top Law Firm by Chambers USA
50
States in Which The Firm Has Successfully Litigated
On the Cutting Edge of the Profession
Legal Intelligencer